Parallax Volatility Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Parallax Volatility Advisers’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,280	Closed	-$225K	–	3405
2020 Q3	$225K	Buy	+4,280	New	+$177K	﹤0.01%	2512
2018 Q2	–	Sell	-620	Closed	-$11K	–	3704
2018 Q1	$11K	Sell	620 -10,594	-94%	-$177K	﹤0.01%	1839
2017 Q4	$156K	Buy	+11,214	New	+$152K	﹤0.01%	2470

Parallax Volatility Advisers's MNTA Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,280 shares — an estimated $225K sold.

Parallax Volatility Advisers first reported a position in MNTA in Q4 2017 and held it in 3 quarters. The position peaked at $225K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Parallax Volatility Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 4,280 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $225K.
Parallax Volatility Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 3 quarters.
Parallax Volatility Advisers's Momenta Pharmaceuticals, Inc. position peaked at $225K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.